This document summarizes the career and research of Dr. Eulogio García focusing on primary angioplasty for acute myocardial infarction. It details his early work in the 1990s establishing primary angioplasty programs in Spain and conducting randomized trials comparing it to thrombolysis. It describes his later involvement in large international multicenter trials that helped establish best practices in primary angioplasty and demonstrated benefits in subgroups. The document outlines over 150 publications and highlights his role in increasing acceptance of primary angioplasty in clinical guidelines.
Presentación "Manejo de la antiagregación ajustada a las pruebas de reactividad plaquetaria. Experiencia, Resultados y futuro de un programa nacional" del Dr. Daniel Aradi durante la Mesa Redonda de Antiagregación de la XXV Reunión Anual de la Sección de Hemodinámica y Cardiología Intervencionista (SHCI) de 2014 en Córdoba.
Presentación "Manejo de la antiagregación ajustada a las pruebas de reactividad plaquetaria. Experiencia, Resultados y futuro de un programa nacional" del Dr. Daniel Aradi durante la Mesa Redonda de Antiagregación de la XXV Reunión Anual de la Sección de Hemodinámica y Cardiología Intervencionista (SHCI) de 2014 en Córdoba.
Six angiographic indicators of large thrombus burden by
Yip and colleagues,depending upon the angiographic morphology are
features indicated “high-burden thrombus formation”:
1. A cut-off pattern of occlusion
2. Accumulated thrombus proximal to the occlusion
3. A reference lumen diameter of the IRA of >4.0 mm
4. An incomplete obstruction with an angiographic thrombus with
the greatest linear dimension more than 3 times the reference
lumen diameter
5. The presence of floating thrombus proximal to the lesion
6. A persistent dye stasis distal to the occlusion
Presentación "Estenosis aórtica riesgo moderado" del Lino Patricio durante la Mesa Redonda Hispano-Lusa sobre Controversias de la XXV Reunión Anual de la Sección de Hemodinámica y Cardiología Intervencionista (SHCI) de 2014 en Córdoba.
SOLACI Chile Congress 2011. Dr.Ajay Kirtane. Drug-Eluting Stents for Multivessel PCI: Indications and Outcomes. Find more presentations on the web site: www.solaci.org/
Presentación "Update de los estudios de ABSORB hasta 2014" del Dr. Flavio Ribichini durante la Mesa Redonda sobre Scaffolds reabsorbibles de la XXV Reunión Anual de la Sección de Hemodinámica y Cardiología Intervencionista (SHCI) de 2014 en Córdoba.
Presentación "Cardiopatía Estructural" del Dr. José María Hernández durante la Mesa Redonda "Novedades en cardiología Intervencionista del último Congreso a este" de la XXV Reunión Anual de la Sección de Hemodinámica y Cardiología Intervencionista (SHCI) de 2014 en Córdoba.
Six angiographic indicators of large thrombus burden by
Yip and colleagues,depending upon the angiographic morphology are
features indicated “high-burden thrombus formation”:
1. A cut-off pattern of occlusion
2. Accumulated thrombus proximal to the occlusion
3. A reference lumen diameter of the IRA of >4.0 mm
4. An incomplete obstruction with an angiographic thrombus with
the greatest linear dimension more than 3 times the reference
lumen diameter
5. The presence of floating thrombus proximal to the lesion
6. A persistent dye stasis distal to the occlusion
Presentación "Estenosis aórtica riesgo moderado" del Lino Patricio durante la Mesa Redonda Hispano-Lusa sobre Controversias de la XXV Reunión Anual de la Sección de Hemodinámica y Cardiología Intervencionista (SHCI) de 2014 en Córdoba.
SOLACI Chile Congress 2011. Dr.Ajay Kirtane. Drug-Eluting Stents for Multivessel PCI: Indications and Outcomes. Find more presentations on the web site: www.solaci.org/
Presentación "Update de los estudios de ABSORB hasta 2014" del Dr. Flavio Ribichini durante la Mesa Redonda sobre Scaffolds reabsorbibles de la XXV Reunión Anual de la Sección de Hemodinámica y Cardiología Intervencionista (SHCI) de 2014 en Córdoba.
Presentación "Cardiopatía Estructural" del Dr. José María Hernández durante la Mesa Redonda "Novedades en cardiología Intervencionista del último Congreso a este" de la XXV Reunión Anual de la Sección de Hemodinámica y Cardiología Intervencionista (SHCI) de 2014 en Córdoba.
El Dr. Juan Miguel Ruiz Nodar defiende el uso del Ticagrelor durante el debate sobre la medicación adyuvante en ACTP Primaria de las Jornadas Nacionales sobre Angioplastia Primaria que se celebraron los días 3 y 4 de julio de 2014 en Ciudad Real.
El Dr. Helder Pereira Horta, presidente de la APIC, analiza la situación de la iniciativa europea Stent for Life/ACTP primaria en Portugal durante las Jornadas Nacionales sobre Angioplastia Primaria que se celebraron los días 3 y 4 de julio de 2014 en Ciudad Real.
El Dr. Ignacio Cruz González defiende el uso del stent MGuard durante el debate "¿Con qué Stent?" de las Jornadas Nacionales sobre Angioplastia Primaria que se celebraron los días 3 y 4 de julio de 2014 en Ciudad Real.
Análisis de la ACTP Primaria en Cataluña realizado por el Dr. Ángel Cequier Fillat durante las Jornadas Nacionales sobre Angioplastia Primaria, organizadas por la SHCI los días 3 y 4 de julio de 2014 en Ciudad Real.
El Dr. Bruno García Del Blanco analiza el uso del stent convencional durante el debate "¿Con qué Stent?" de las Jornadas Nacionales sobre Angioplastia Primaria que se celebraron los días 3 y 4 de julio de 2014 en Ciudad Real.
El Dr. Andrés Iñiguez Romo presenta el Registro Estatal del IAM durante las conclusiones y clausura de las Jornadas Nacionales sobre Angioplastia Primaria que se celebraron los días 3 y 4 de julio de 2014 en Ciudad Real.
Análisis de la ACTP Primaria en La Rioja realizado por el Dr. Luis Alonso Pérez durante las Jornadas Nacionales sobre Angioplastia Primaria, organizadas por la SHCI los días 3 y 4 de julio de 2014 en Ciudad Real.
El Dr. Alfonso Jurado Román defiende el uso del Prasugrel durante el debate sobre la medicación adyuvante en ACTP Primaria de las Jornadas Nacionales sobre Angioplastia Primaria que se celebraron los días 3 y 4 de julio de 2014 en Ciudad Real.
El Dr. Joan Antoni Gómez Hospital defiende el uso del stent Titán durante el debate "¿Con qué Stent?" de las Jornadas Nacionales sobre Angioplastia Primaria que se celebraron los días 3 y 4 de julio de 2014 en Ciudad Real.
Presentación sobre la ACTP Primaria en Cantabria realizada por el Dr. José María De La Torre Hernández durante las Jornadas Nacionales sobre Angioplastia Primaria, organizadas por la SHCI los días 3 y 4 de julio de 2014 en Ciudad Real.
Presentación sobre la ACTP Primaria en Canarias realizada por el Dr. Francisco Bosa Ojeda durante las Jornadas Nacionales sobre Angioplastia Primaria, organizadas por la SHCI los días 3 y 4 de julio de 2014 en Ciudad Real.
Presentación sobre la ACTP Primaria en Baleares realizada por el Dr. Armando Bethencourt González durante las Jornadas Nacionales sobre Angioplastia Primaria, organizadas por la SHCI los días 3 y 4 de julio de 2014 en Ciudad Real.
Presentación sobre la ACTP Primaria en Aragón realizada por el Dr. José Ramón Ruiz Arroyo durante las Jornadas Nacionales sobre Angioplastia Primaria, organizadas por la SHCI los días 3 y 4 de julio de 2014 en Ciudad Real.
Presentación sobre la ACTP Primaria en Castilla y León realizada por el Dr. Felipe Fernández Vázquez durante las Jornadas Nacionales sobre Angioplastia Primaria, organizadas por la SHCI los días 3 y 4 de julio de 2014 en Ciudad Real.
Dr. Nicolás Vázquez González defiende en esta presentación el acceso radial durante el debate: "¿Por Dónde?" de las Jornadas Nacionales sobre Angioplastia Primaria que se celebraron los días 3 y 4 de julio de 2014 en Ciudad Real.
Coronary artery bypass grafting with adjunctive
endarterectomy: A mandatory procedure in complex
revascularizations. current results and postoperative
considerations
CTO PCI and length of dual antiplatelet regimenEuro CTO Club
CTO PCI and length of dual antiplatelet regimen
Maciej Lesiak, Poznan, Poland
11th Experts Live CTO
The annual Euro CTO meeting
September 13th –14th, 2019 - Berlin, Germany
Ponencia presentada por el Dr. J. Raúl Moreno Gómez en el directo 'Controversias en tratamiento antitrombótico – Parte II', realizado el 6 de abril de 2021
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
2. Julio 1991. Hospital Universitario Gregorio Marañón
Inspiración: “In Laboratory events during
primary angioplasty“ Kahn/Haztler group . Circulation, 1991
Motivación: Incrementar actividad C.
Intervencionista
Apoyo: Jefe de servicio ( J.L. Delcán)
dirección, enfermería
Oposición: Médicos U.C. y el club t-pa
3. Compromiso
Estudio Randomizado de Infarto Anterior (
AP vs t-pa )
Paciente con menos de 5 horas desde
comienzo del dolor
Los pacientes con IAM anterior y
contraindicación fibrinolisis…AP
Pacientes con infartos extensos…AP
Pacientes con Killip 3-4…AP
Muy pronto…todos AP. Dificultad para
incluir pacientes en protocolo
4. Impacto
Incremento actividad 25%
Recelo exterior
Debates
Dificultad en convencer autoridades de
establecimiento de redes
Rentabilidad : mejoría progresiva de
resultados y producción científica
5. Acumulación de experiencia clínica
1. Capacidad de respuesta : 40 minutos
llamada – balón
2. Establecimiento de sistemática de trabajo (
condicionamiento clínico )
3. 1991-2000 : más de 2000 casos realizados
4. Introducción de cambios en tratamiento :
stent, antiplaquetarios, aspiración …etc
5. Tratamiento de elección en cualquier
contexto clínico
17. CONVENCIMIENTO ADMINISTRATIVO
Tiene Madrid los medios necesarios ?
1. Situación geográfica idónea
2. Sistema de trasporte médico adecuado
3. Población concentrada
4. Hospitales preparados,
con experiencia, geográficamente
bien situados
18. CONCLUSIONES
Con tiempos de traslado razonables, los resultados de
ACTP primaria post –traslado son superiores al
tratamiento trombolítico in situ.
A la espera de resultados de angioplastia facilitada, parece
razonable el tratamiento antiagragante pre-traslado.
Las premisas anteriores y experiencia
en otras disciplinas ( trauma, cancer )
indican la necesidad urgente de centros
de infarto.
19. INICIATIVAS Y RESPUESTAS
COLABORACIÓN CON SISTEMAS DE TRASPORTE
1. Sesiones de información y proyectos
2. Elaboración de programa de colaboración
3. Buena acogida de la iniciativa
20. RESPUESTA ADMINISTRATIVA
Proyecto presentado en 2001 : RIMA
Respuesta : Silencio
Razones : Proyecto inadecuado ?,
Argumentación poco convincente?
Temor al gasto ?
Influencias negativas ajenas ?
21. EDITORIAL
[Primary angioplasty: this balloon is of
general interest, indeed]. Eulogio García Revista
Esp de Cardiologia 07/2002; 55(6):565-7. · 3.20 Impact Factor
22. ESTUDIOS MONOCENTRICOS
[Primary coronary angioplasty in acute anterior myocardial infarction:
immediate results].
E J García, J L Delcán, J Elízaga, M Abeytua, J Soriano, J A García Robles, J Botas, L
López-Bescós, T Echeverría, A Beloscar
[show abstract]
Revista Espa de Cardiologia 02/1994; 47(1):40-6. · 3.20 Impact Factor
Primary angioplasty versus systemic thrombolysis in anterior myocardial
infarction.
E García, J Elízaga, N Pérez-Castellano, J A Serrano, J Soriano, M Abeytua, J Botas, R
Rubio, E López de Sá, J L López-Sendón, J L Delcán
[Show abstract]
Journal of the American College of Cardiology 03/1999; 33(3):605-11. · 14.09 Impact
Factor
23. METANÁLISIS
Comparison of Primary Coronary Angioplasty and Intravenous
Thrombolytic Therapy for Acute Myocardial InfarctionA Quantitative
Review
W. Douglas Weaver, R. John Simes, Amadeo Betriu, Cindy L. Grines, Felix Zijlstra,
Eulogio Garcia, Lilliana Grinfeld, Raymond J. Gibbons, Expedito E. Ribeiro, Marcus A.
DeWood, Flavio Ribichini
[show abstract]
JAMA The Journal of the American Medical Association 278(23):2093-2098. · 29.98
Impact Factor
24. ESTUDIOS MULTICENTRICOS
Coronary angioplasty with or without stent implantation for acute
myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction
Study Group.
C L Grines, D A Cox, G W Stone, E Garcia, L A Mattos, A Giambartolomei, B R
Brodie, O Madonna, M Eijgelshoven, A J Lansky, W W O'Neill, M C Morice
[Show abstract]
New England Journal of Medicine 12/1999; 341(26):1949-56. · 51.66 Impact Factor
Comparison of angioplasty with stenting, with or without abciximab, in
acute myocardial infarction.
Gregg W Stone, Cindy L Grines, David A Cox, Eulogio Garcia, James E Tcheng, John J
Griffin, Giulio Guagliumi, Thomas Stuckey, Mark Turco, John D Carroll, Barry D
Rutherford, Alexandra J Lansky
[show abstract]
New England Journal of Medicine 04/2002; 346(13):957-66. · 51.66 Impact Factor
25. ROTURA CARDIACA
Primary angioplasty reduces the risk of left ventricular free wall rupture
compared with thrombolysis in patients with acute myocardial infarction.
Raúl Moreno, José López-Sendón, Eulogio García, Leopoldo Pérez de Isla, Esteban López
de Sá, Ana Ortega, Mar Moreno, Rafael Rubio, Javier Soriano, Manuel Abeytua, Miguel-
Angel García-Fernández
[show abstract]
Journal of the American College of Cardiology 02/2002; 39(4):598-603. · 14.09 Impact
Factor
Frequency of left ventricular free-wall rupture in patients with acute
myocardial infarction treated with primary angioplasty.
R Moreno, E López de Sá, J L López-Sendón, E García, J Soriano, M Abeytua, J Elízaga,
J Botas, R Rubio, M Moreno, M A García-Fernández, J L Delcán
[Show abstract]
The American Journal of Cardiology 04/2000; 85(6):757-60, A8. · 3.21 Impact Factor
26. CIRCULACION COLATERAL
Influence of collateral circulation on in-hospital death from anterior acute
myocardial infarction.
N Pérez-Castellano, E J García, M Abeytua, J Soriano, J A Serrano, J Elízaga, J Botas, J
L López-Sendón, J L Delcán
[show abstract]
Journal of the American College of Cardiology 03/1998; 31(3):512-8. · 14.09 Impact
Factor
27. EDAD Y SEXO
Outcome in elderly patients undergoing primary coronary intervention for
acute myocardial infarction: results from the Controlled Abciximab and Device
Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
Giulio Guagliumi, Gregg W Stone, David A Cox, Thomas Stuckey, James E Tcheng, Mark
Turco, Giuseppe Musumeci, John J Griffin, Alexandra J Lansky, Roxana Mehran, Cindy L
Grines, Eulogio Garcia
[show abstract]
Circulation 09/2004; 110(12):1598-604. · 15.20 Impact Factor
Gender differences in outcomes after primary angioplasty versus primary
stenting with and without abciximab for acute myocardial infarction: results of
the Controlled Abciximab and Device Investigation to Lower Late Angioplasty
Complications (CADILLAC) trial.
Alexandra J Lansky, Cody Pietras, Ricardo A Costa, Yoshihiro Tsuchiya, Bruce R Brodie,
David A Cox, Eve D Aymong, Thomas D Stuckey, Eulogio Garcia, James E Tcheng, Roxana
Mehran, Manuela Negoita, Martin Fahy, Ecaterina Cristea, Mark Turco, Martin B Leon,
Cindy L Grines, Gregg W Stone
[show abstract]
Circulation 04/2005; 111(13):1611-8. · 15.20 Impact Factor
28. PERFUSION MIOCÁRDICA
Combined prognostic utility of ST-segment recovery and myocardial blush after
primary percutaneous coronary intervention in acute myocardial infarction.
Paul Sorajja, Bernard J Gersh, Costantino Costantini, Michael G McLaughlin, Peter
Zimetbaum, David A Cox, Eulogio Garcia, James E Tcheng, Roxana Mehran, Alexandra J
Lansky, David E Kandzari, Cindy L Grines, Gregg W Stone
[show abstract]
European Heart Journal 05/2005; 26(7):667-74. · 14.10 Impact Factor
Relationship between infarct artery location, epicardial flow, and myocardial
perfusion after primary percutaneous revascularization in acute myocardial
infarction.
David E Kandzari, James E Tcheng, Bernard J Gersh, David A Cox, Thomas Stuckey, Mark
Turco, Roxana Mehran, Eulogio Garcia, Peter Zimetbaum, Michael G McGlaughlin,
Alexandra J Lansky, Costantino O Costantini, Cindy L Grines, Gregg W Stone
[show abstract]
American heart journal 06/2006; 151(6):1288-95. · 4.65 Impact Factor
Impact of ST-segment resolution after primary angioplasty on outcomes after
myocardial infarction in elderly patients: an analysis from the CADILLAC trial.
Abhiram Prasad, Gregg W Stone, Eve Aymong, Peter J Zimetbaum, Michael McLaughlin,
Roxana Mehran, Eulogio Garcia, James E Tcheng, David A Cox, Cindy L Grines, Bernard J
Gersh [show abstract]
American heart journal 04/2004; 147(4):669-75. · 4.65 Impact Factor
29. PERFUSION MIOCÁRDICA
Prognostic utility of comparative methods for assessment of ST-segment
resolution after primary angioplasty for acute myocardial infarction: the
Controlled Abciximab and Device Investigation to Lower Late Angioplasty
Complications (CADILLAC) trial.
Michael G McLaughlin, Gregg W Stone, Eve Aymong, Graham Gardner, Roxana Mehran,
Alexandra J Lansky, Cindy L Grines, James E Tcheng, David A Cox, Thomas Stuckey,
Eulogio Garcia, Giulio Guagliumi, Mark Turco, Mark E Josephson, Peter Zimetbaum
[show abstract]
Journal of the American College of Cardiology 09/2004; 44(6):1215-23. · 14.09 Impact
Factor
Frequency, correlates, and clinical implications of myocardial perfusion after
primary angioplasty and stenting, with and without glycoprotein IIb/IIIa
inhibition, in acute myocardial infarction.
Costantino O Costantini, Gregg W Stone, Roxana Mehran, Eve Aymong, Cindy L Grines,
David A Cox, Thomas Stuckey, Mark Turco, Bernard J Gersh, James E Tcheng, Eulogio
Garcia, John J Griffin, Giulio Guagliumi, Martin B Leon, Alexandra J Lansky
[show abstract]
Journal of the American College of Cardiology 08/2004; 44(2):305-12. · 14.09 Impact
Factor
30. PLATELETS
Impact of in-hospital acquired thrombocytopenia in patients undergoing
primary angioplasty for acute myocardial infarction.
Eugenia Nikolsky, H Mehrdad Sadeghi, Mark B Effron, Roxana Mehran, Alexandra J
Lansky, Yingbo Na, David A Cox, Eulogio Garcia, James E Tcheng, John J Griffin,
Thomas D Stuckey, Mark Turco, John D Carroll, Cindy L Grines, Gregg W Stone
[show abstract]
The American Journal of Cardiology 08/2005; 96(4):474-81. · 3.21 Impact Factor
Impact of baseline platelet count in patients undergoing primary
percutaneous coronary intervention in acute myocardial infarction (from
the CADILLAC trial).
Eugenia Nikolsky, Cindy L Grines, David A Cox, Eulogio Garcia, James E Tcheng,
Mehrdad Sadeghi, Roxana Mehran, Alexandra J Lansky, Yingbo Na, Gregg W Stone
[show abstract]
The American Journal of Cardiology 04/2007; 99(8):1055-61. · 3.21 Impact Factor
31. REOPRO
Benefits and risks of abciximab use in primary angioplasty for acute myocardial
infarction: the Controlled Abciximab and Device Investigation to Lower Late
Angioplasty Complications (CADILLAC) trial.
James E Tcheng, David E Kandzari, Cindy L Grines, David A Cox, Mark Effron, Eulogio
Garcia, John J Griffin, Giulio Guagliumi, Thomas Stuckey, Mark Turco, Martin Fahy,
Alexandra J Lansky, Roxana Mehran, Gregg W Stone
[show abstract]
Circulation 10/2003; 108(11):1316-23. · 15.20 Impact Factor
Impact of stenting and abciximab in patients with diabetes mellitus undergoing primary
angioplasty in acute myocardial infarction (the CADILLAC trial).
Thomas D Stuckey, Gregg W Stone, David A Cox, James E Tcheng, Eulogio Garcia, John
Carroll, Giulio Guagliumi, Barry D Rutherford, John J Griffin, Mark Turco, Alexandra J
Lansky, Roxana Mehran, Martin Fahy, Bruce R Brodie, Cindy L Grines
[show abstract]
The American Journal of Cardiology 02/2005; 95(1):1-7. · 3.21 Impact Factor
Outcomes following bail-out abciximab administration during primary intervention in
acute myocardial infarction (The CADILLAC Trial).
Dale T Ashby, Eve A Aymong, James E Tcheng, Cindy L Grines, David A Cox, Roxana
Mehran, Eulogio Garcia, John J Griffin, Giulio Guagliumi, Thomas Stuckey, Mark Turco,
Alexandra J Lansky, Gregg W Stone
[show abstract]
The American Journal of Cardiology 12/2003; 92(9):1091-4. · 3.21 Impact Factor
32. ASPIRACION DE TROMBO STENT.
Mid-term results of thrombus extraction in patients with ST elevation
myocardial infarction: One center experience with the X-SIZER catheter
system
Eulogio Garcia, Alejandro Alvarez, Jose M. Cubero, Agustin LaCorte, Manuel Abeytua,
Jose L. Lopez-Sendon, Esteban Lopez de Sa, Amalia Mota
Journal of the American College of Cardiology , 2003; 41:356. · 14.09 Impact Factor
XAMINE ST trial
T. Lefevre, E. Garcia, Reimers B et al. JACC 2005;46:246-252. 14.09 Impact factor
Journal of the American College of Cardiology,
[Results of coronary stenting in acute myocardial infarction].
R Moreno, E García, J Soriano, M Abeytua, J Elízaga, J Botas, J L López Sendón, J L
Delcán
[Show abstract]
Revista Espa de Cardiologia 01/2000; 53(1):27-34. · 3.20 Impact Factor
33. NEUTROPHILS
Relation between leucocyte count, myonecrosis, myocardial perfusion, and
outcomes following primary angioplasty.
Abhiram Prasad, Gregg W Stone, Thomas D Stuckey, Costantino O Costantini, Roxana
Mehran, Eulogio Garcia, James E Tcheng, David A Cox, Cindy L Grines, Alexandra J
Lansky, Bernard J Gersh
[show abstract]
The American Journal of Cardiology 04/2007; 99(8):1067-71. · 3.21 Impact Factor
Neutrophil count and infarct size in patients with acute myocardial infarction.
Pablo Avanzas, Juan Quiles, Esteban López de Sá, Ana Sánchez, Rafael Rubio, Eulogio
García, José Luis López-Sendón
International Journal of Cardiology 11/2004; 97(1):155-6. · 5.51 Impact Factor
34. MULTIVASO, SHOCK.
[Results of primary angioplasty in patients with multivessel
disease].
R Moreno, E García, J Elízaga, M Abeytua, J Soriano, J Botas, J L López-Sendón, J L
Delcán
[Show abstract]
Revista Espa de Cardiologia 07/1998; 51(7):547-55. · 3.20 Impact Factor
Efficacy of invasive strategy for the management of acute
myocardial infarction complicated by cardiogenic shock.
N Pérez-Castellano, E García, J A Serrano, J Elízaga, J Soriano, M Abeytua, J Botas, R
Rubio, E López de Sá, J L López-Sendón, J L Delcán
[Show abstract]
The American Journal of Cardiology 05/1999; 83(7):989-93. · 3.21 Impact Factor
35. INSUFICIENCIA RENAL
Impact of renal insufficiency in patients undergoing primary angioplasty
for acute myocardial infarction.
H Mehrdad Sadeghi, Gregg W Stone, Cindy L Grines, Roxana Mehran, Simon R Dixon,
Alexandra J Lansky, Martin Fahy, David A Cox, Eulogio Garcia, James E Tcheng, John J
Griffin, Thomas D Stuckey, Mark Turco, John D Carroll
[show abstract]
Circulation 12/2003; 108(22):2769-75. · 15.20 Impact Factor
36. RESCATE, GUIAS
Coronary stenting during rescue angioplasty after failed thrombolysis.
R Moreno, E García, M Abeytua, J Soriano, J Elizaga, J Botas, J L López-Sendón, J L
Delcán
[Show abstract]
Catheterization and Cardiovascular Interventions 06/1999; 47(1):1-5. · 2.51 Impact Factor
[The clinical management guidelines of the Sociedad Española de Cardiología
in acute myocardial infarct].
F Arós, A Loma-Osorio, A Alonso, J J Alonso, A Cabadés, I Coma-Canella, L García-
Castrillo, E García, E López de Sá, P Pabón, J M San José, A Vera, F Worner
[Show abstract]
Revista Espa de Cardiologia 11/1999; 52(11):919-56. · 3.20 Impact Factor
37. BETA-BLOQUEANTES
Impact of intravenous beta-blockade before primary angioplasty on survival
in patients undergoing mechanical reperfusion therapy for acute myocardial
infarction.
Amir Halkin, Cindy L Grines, David A Cox, Eulogio Garcia, Roxana Mehran, James E
Tcheng, John J Griffin, Giulio Guagliumi, Bruce Brodie, Mark Turco, Barry D
Rutherford, Eve Aymong, Alexandra J Lansky, Gregg W Stone
[show abstract]
Journal of the American College of Cardiology 06/2004; 43(10):1780-7. · 14.09 Impact
Factor
Effects of prior beta-blocker therapy on clinical outcomes after primary
coronary angioplasty for acute myocardial infarction.
Kishore J Harjai, Gregg W Stone, Judith Boura, Lorelei Grines, Eulogio Garcia, Bruce
Brodie, David Cox, William W O'Neill, Cindy Grines
[show abstract]
The American Journal of Cardiology 04/2003; 91(6):655-60. · 3.21 Impact Factor
38. TOTAL
PUBLICACIONES:
242
FACTOR DE IMPACTO: 1130.32
IAM
PUBLICACIONES : 68
FACTOR DE IMPACTO : 475.66